At 0.4x sales and 9.4x forward earnings, the market is pricing LILAK like a distressed asset, and the 0.2 Altman Z-Score confirms that distress is not theoretical. An operating margin of -110.00% combined with ROIC of -0.60% signals value destruction at the operating level, yet the company trades at just $1,653M in market cap with a TTM yield of 15.1, suggesting extreme pessimism is already embedded. The absence of a trailing P/E but a 9.4 Forward P/E implies a sharp earnings normalization narrative despite EPS Next Year (Est.) of -$3.06, which creates internal inconsistency and highlights earnings volatility. This is not a safe balance sheet story; it is a highly levered turnaround speculation where survival, not growth, is the central question.